GRDN peer analysis
Guardian Pharmacy (GRDN) against its competitors: price, today's move, 1-year return and market value side by side.
GRDN and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| EWTX Edgewise Therapeutics | $45.28 | 16.48% | 160.66% | – |
| JANX Janux | $17.63 | 9.78% | -35.98% | – |
| MD Pediatrix | $31.29 | -1.73% | 44.26% | $2.44B |
| MESO Mesoblast | $14.27 | 1.21% | -8.17% | $1.86B |
| NHC National Healthcare | $213.00 | 2.59% | 70.50% | $3.34B |
| NUVB Nuvation Bio | $4.19 | 0.00% | -14.84% | – |
| PRCT PROCEPT BioRobotics | $20.57 | 1.48% | -34.93% | – |
| QDEL QuidelOrtho | $10.97 | -14.53% | -59.90% | $752.59M |
| TWST Twist Bioscience | $120.79 | 0.15% | 283.22% | $7.57B |
| TXG 10x Genomics | $61.20 | 5.41% | 353.67% | $7.36B |
| GRDN Guardian Pharmacy | $42.39 | 6.32% | 46.22% | – |
- GRDN's peers: EWTX (Edgewise Therapeutics), JANX (Janux), MD (Pediatrix), MESO (Mesoblast), NHC (National Healthcare), NUVB (Nuvation Bio), PRCT (PROCEPT BioRobotics), QDEL (QuidelOrtho).
Updated 2026-11-07 11:54 UTC